These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19646419)

  • 1. NIK is involved in constitutive activation of the alternative NF-kappaB pathway and proliferation of pancreatic cancer cells.
    Nishina T; Yamaguchi N; Gohda J; Semba K; Inoue J
    Biochem Biophys Res Commun; 2009 Oct; 388(1):96-101. PubMed ID: 19646419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y; Martínez Bruyn VJ; Uota S; Hasegawa A; Yamamoto N; Imoto I; Inazawa J; Yamaoka S
    Lung Cancer; 2010 Dec; 70(3):263-70. PubMed ID: 20338663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation.
    Qing G; Yan P; Qu Z; Liu H; Xiao G
    Cell Res; 2007 Jun; 17(6):520-30. PubMed ID: 17563756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.
    Fusco AJ; Mazumder A; Wang VY; Tao Z; Ware C; Ghosh G
    Sci Signal; 2016 Sep; 9(447):ra96. PubMed ID: 27678221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.
    Schneider G; Saur D; Siveke JT; Fritsch R; Greten FR; Schmid RM
    EMBO J; 2006 Aug; 25(16):3801-12. PubMed ID: 16902410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
    Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
    J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.
    Fritz RD; Radziwill G
    Mol Cancer Res; 2010 Mar; 8(3):395-406. PubMed ID: 20197385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C; Dejardin E
    Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
    Ma L; Shen YY; Zhou P; Zhou J; Guo F
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
    Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
    Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor signaling contributes to constitutive activation of the noncanonical NF-κB pathway in term human placenta.
    Wang B; Palomares K; Parobchak N; Cece J; Rosen M; Nguyen A; Rosen T
    Mol Endocrinol; 2013 Feb; 27(2):203-11. PubMed ID: 23239753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
    Dejardin E
    Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.
    Choudhary S; Boldogh S; Garofalo R; Jamaluddin M; Brasier AR
    J Virol; 2005 Jul; 79(14):8948-59. PubMed ID: 15994789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
    Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
    Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.
    Vaira S; Johnson T; Hirbe AC; Alhawagri M; Anwisye I; Sammut B; O'Neal J; Zou W; Weilbaecher KN; Faccio R; Novack DV
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3897-902. PubMed ID: 18322009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB p52, RelB and c-Rel are transported into the nucleus via a subset of importin alpha molecules.
    Fagerlund R; Melén K; Cao X; Julkunen I
    Cell Signal; 2008 Aug; 20(8):1442-51. PubMed ID: 18462924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
    Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
    Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.